Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
Genomic Health to Present at Canaccord Adams 29th Annual Global Growth Conference
Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress
Genomic Health Delivers Online Perspective
Genomic Health to Announce Second Quarter 2009 Financial Results and Host Conference Call on Tuesday, August 4, 2009
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer
Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women
Oncotype DX(R) Guides Individualized Treatment Decisions for More Than 100,000 Breast Cancer Patients Worldwide
Genomic Health to Present Multiple New Studies at the American Society of Clinical Oncology Annual Meeting
Genomic Health's Oncotype DX(R) Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients
Genomic Health to Present at JMP Securities Research Conference
Genomic Health Announces First Quarter 2009 Financial Results and Business Progress
Genomic Health to Announce First Quarter 2009 Financial Results and Host Conference Call on Tuesday, May 5, 2009
Genomic Health Announces Study Confirming Prognostic Value of Oncotype DX(R) Recurrence Score(R) Result in Japanese Breast Cancer Patients
Genomic Health Announces Positive Preliminary Results from QUASAR Validation Study of Oncotype DX(R) Colon Cancer Assay
Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance
Genomic Health to Announce Fourth Quarter and Year-End 2008 Financial Results and Host Conference Call on Tuesday, February 3, 2009
Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
Genomic Health Announces Management Changes and New Responsibilities
Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors
Genomic Health Announces Appointment of Ginger Graham to Board of Directors
Genomic Health to Present Multiple New Studies at 31st Annual San Antonio Breast Cancer Symposium
Genomic Health to Present at Stephens Fall Investment Conference
Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated
Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress
Genomic Health to Announce Third Quarter 2008 Financial Results and Host Conference Call on Wednesday, November 5, 2008
Wall Street Media Presents Exclusive Videos from the JMP Healthcare Focus Conference - Oct 8 2008 3:21PM
Genomic Health to Present at JMP Securities Healthcare Focus Conference
Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients
Genomic Health Announces Publication of a Study Comparing Oncotype DX(R) and Adjuvant! Online in Node-Negative and Node-Positive Hormone Receptor-Positive Breast Cancer Patients
Zacks Bull and Bear of the Day Highlights: Vale Do Rio Doce, Deckers Outdoor, Barclays, Genomic Health and Newfield Exploration
Genomic Health Announces Second Quarter 2008 Financial Results and Business Progress
Genomic Health to Announce Second Quarter 2008 Financial Results and Host Conference Call on Tuesday, August 5, 2008
Genomic Health Announces Expansion of Oncotype DX(R) Breast Cancer Test to Include Quantitative Estrogen Receptor (ER) and Progesterone Receptor (PR) Scores
Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies
Genomic Health to Present at Bank of America 2008 Healthcare Conference and 7th Annual JMP Securities Research Conference - Jun 3 2008 3:14AM
Genomic Health Announces First Quarter 2008 Financial Results and Business Progress - Jun 3 2008 3:14AM
Genomic Health to Announce First Quarter 2008 Financial Results and Host Conference Call on Tuesday, May 6, 2008
Genomic Health to Present at Morgan Stanley Global Healthcare Unplugged Conference
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia